Processa Pharmaceuticals, Inc. has filed Supplement No. 1 to its definitive proxy statement with the SEC on April 29, 2024, in preparation for its Annual Meeting of Stockholders scheduled for June 28, 2024. The supplement provides a Pay Versus Performance Table, which includes detailed disclosures of executive compensation in accordance with SEC rules. The table reveals the compensation actually paid to the principal executive officers (PEOs) and non-PEO named executive officers (NEOs) for the years 2021, 2022, and 2023. The report indicates that the compensation figures are calculated as per SEC guidelines and do not represent the actual amounts earned by the executives. The supplement also includes a descriptive disclosure with graphs illustrating the relationship between the compensation paid to executives and the company's total shareholder return and net income for the same periods. This additional material is intended to inform shareholders ahead of the upcoming annual meeting where voting on company matters will take place.

Processa Pharmaceuticals, Inc. has filed Supplement No. 1 to its definitive proxy statement with the SEC on April 29, 2024, in preparation for its Annual Meeting of Stockholders scheduled for June 28, 2024. The supplement provides a Pay Versus Performance Table, which includes detailed disclosures of executive compensation in accordance with SEC rules. The table reveals the compensation actually paid to the principal executive officers (PEOs) and non-PEO named executive officers (NEOs) for the years 2021, 2022, and 2023. The report indicates that the compensation figures are calculated as per SEC guidelines and do not represent the actual amounts earned by the executives. The supplement also includes a descriptive disclosure with graphs illustrating the relationship between the compensation paid to executives and the company's total shareholder return and net income for the same periods. This additional material is intended to inform shareholders ahead of the upcoming annual meeting where voting on company matters will take place.